FINWIRES · TerminalLIVE
FINWIRES

Harmony Biosciences股价在公布第一季度财报后下跌,营收不及预期

By

-- Harmony Biosciences (HRMY) 股价周四下跌超过 6%,此前该公司公布的第一季度盈利和营收均低于分析师预期。 该公司公布的第一季度稀释后每股收益为 0.55 美元,低于去年同期的 0.78 美元。 FactSet 调查的分析师此前预期为 0.69 美元。 截至 3 月 31 日的第一季度,净产品收入为 2.154 亿美元,高于去年同期的 1.847 亿美元。 分析师此前预期收入为 2.208 亿美元。 截至 3 月 31 日,该公司表示其现金、现金等价物和投资总额为 8.705 亿美元。 该公司重申了其 2026 年 WAKIX 净收入预期,为 10 亿美元至 10.4 亿美元。分析师此前预期为 10.1 亿美元。

Price: $29.52, Change: $-3.26, Percent Change: -9.95%

Related Articles

Australia

Max Resource Applies for OTCQB Listing; Shares Down 8.2%

Max Resource (MAX.V) on Thursday said it applied to list its shares on the U.S. OTCQB market.The company's shares will continue to trade on the Toronto Stock Exchange Venture under it current symbol, it said.The company's OTCQB application is subject to OTC Markets' review and approval.The company's shares are eligible for settlement through the Depository Trust Company (DTC), which facilitates the electronic clearing and settlement of publicly traded companies in the United States, the company added."We believe that uplisting on the OTCQB would expand Max's exposure to U.S. investors, increase trading accessibility and liquidity, and support the company's efforts to build a broader international shareholder base as the exploration season advances into full swing," said chief executive Brett Matich.The company's shares were last seen down $0.025 at $0.28 on the TSX Venture Exchange.Price: $0.28, Change: $-0.03, Percent Change: -8.20%

$MAX.V
Australia

Macquarie Downgrades PayPal to Neutral From Outperform, Price Target is $50

PayPal (PYPL) has an average rating of hold and mean price target of $50.09, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $46.94, Change: $+0.68, Percent Change: +1.46%

$PYPL
Australia

Fortinet Set for Faster Growth on Cyber Risk, AI Upgrades, Wedbush Says

Fortinet (FTNT) is positioned for stronger growth as AI-driven infrastructure needs, rising cyber risks, product upgrades, vendor consolidation, and improving sales momentum support its revenue and billings outlook, Wedbush Securities said Thursday in a report.Q1 billings rose 31% to $2.09 billion, above Wall Street estimates, with strength across security operations and operational technology security, the report said. Revenue climbed 20%, helped by large customers upgrading to higher-performance systems for AI-related workloads, Wedbush said.Operating margins and earnings per share both exceeded expectations on strong execution and cost control, Wedbush said. Fortinet raised its 2026 revenue and billings outlook as cyber threats, data security needs, and cost pressures push customers toward broader cyber platforms, the report said.Wedbush raised its price target on Fortinet stock to $125 from $90 and maintained its outperform rating, citing greater confidence in the company's growth recovery.Price: $110.88, Change: $+20.93, Percent Change: +23.27%

$FTNT